The opposite effects of doxorubicin on bone marrow stem cells versus breast cancer stem cells depend on glucosylceramide synthase

Al-Hajj, 2003, Prospective identification of tumorigenic breast cancer cells, Proceedings of the National Academy of Sciences of the United States of America, 100, 3983, 10.1073/pnas.0530291100 Bartsch, 2009, The role of supportive therapy in the era of modern adjuvant treatment – current and future tools, Breast Care (Basel), 4, 167, 10.1159/000223360 Brimble, 2007, The cell surface glycosphingolipids SSEA-3 and SSEA-4 are not essential for human ESC pluripotency, Stem Cells, 25, 54, 10.1634/stemcells.2006-0232 Busch, 1990, Toxicity of novel anthracycline derivatives towards normal myeloid bone marrow progenitor cells (CFU-GM) is not increased by verapamil, Blut, 60, 219, 10.1007/BF01728787 Calcagno, 2010, Prolonged drug selection of breast cancer cells and enrichment of cancer stem cell characteristics, Journal of the National Cancer Institute, 102, 1637, 10.1093/jnci/djq361 Carey, 2003, Drug-induced myelosuppression: diagnosis and management, Drug Safety, 26, 691, 10.2165/00002018-200326100-00003 Clarke, 1992, Effect of P-glycoprotein expression on sensitivity to hormones in MCF-7 human breast cancer cells, Journal of the National Cancer Institute, 84, 1506, 10.1093/jnci/84.19.1506 Daniel, 2006, Myelotoxicity from chemotherapy, Seminars in Oncology, 33, 74, 10.1053/j.seminoncol.2005.11.003 Dean, 2005, Tumour stem cells and drug resistance, Nature Reviews Cancer, 5, 275, 10.1038/nrc1590 Doyle, 1998, A multidrug resistance transporter from human MCF-7 breast cancer cells, Proceedings of the National Academy of Sciences of the United States of America, 95, 15665, 10.1073/pnas.95.26.15665 Fillmore, 2008, Human breast cancer cell lines contain stem-like cells that self-renew, give rise to phenotypically diverse progeny and survive chemotherapy, Breast Cancer Research, 10, R25, 10.1186/bcr1982 Gasparini, 1995, Expression of bcl-2 protein predicts efficacy of adjuvant treatments in operable node-positive breast cancer, Clinical Cancer Research, 1, 189 Giarratana, 2005, Ex vivo generation of fully mature human red blood cells from hematopoietic stem cells, Nature Biotechnology, 23, 69, 10.1038/nbt1047 Gonzalez-Angulo, 2007, Overview of resistance to systemic therapy in patients with breast cancer, Advances in Experimental Medicine and Biology, 608, 1, 10.1007/978-0-387-74039-3_1 Goodell, 1996, Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo, Journal of Experimental Medicine, 183, 1797, 10.1084/jem.183.4.1797 Gupta, 2010, Direct quantitative determination of ceramide glycosylation in vivo: a new approach to evaluate cellular enzyme activity of glucosylceramide synthase, Journal of Lipid Research, 51, 866, 10.1194/jlr.D002949 Gupta, 2011, Evaluation of anticancer agents using flow cytometry analysis of cancer stem cells, Methods in Molecular Biology, 716, 179, 10.1007/978-1-61779-012-6_11 Hakomori, 2008, Structure and function of glycosphingolipids and sphingolipids: recollections and future trends, Biochimica et Biophysica Acta, 1780, 325, 10.1016/j.bbagen.2007.08.015 Herman, 2006, Implications of increased tissue transglutaminase (TG2) expression in drug-resistant breast cancer (MCF-7) cells, Oncogene, 25, 3049, 10.1038/sj.onc.1209324 Hood, 2003, Chemotherapy in the elderly: supportive measures for chemotherapy-induced myelotoxicity, Clinical Journal of Oncology Nursing, 7, 185, 10.1188/03.CJON.185-190 Ichikawa, 1998, Glucosylceramide synthase and glycosphingolipid synthesis, Trends in Cell Biology, 8, 198, 10.1016/S0962-8924(98)01249-5 Janni, 2001, Chemotherapy-associated myelosuppression in gynecological oncology, Gynakologisch-Geburtshilfliche Rundschau, 41, 166, 10.1159/000049471 Jimenez, 1992, Protection from chemotherapy-induced neutropenia by ImuVert, American Journal of the Medical Sciences, 303, 83, 10.1097/00000441-199202000-00003 Klimanskaya, 2006, Human embryonic stem cell lines derived from single blastomeres, Nature, 444, 481, 10.1038/nature05142 Kobayashi, 2011, Side population is increased in paclitaxel-resistant ovarian cancer cell lines regardless of resistance to cisplatin, Gynecologic Oncology, 121, 390, 10.1016/j.ygyno.2010.12.366 Kroger, 1999, Current options in treatment of anthracycline-resistant breast cancer, Cancer Treatment Reviews, 25, 279, 10.1053/ctrv.1999.0137 Lagadec, 2012, Radiation-induced reprogramming of breast cancer cells, Stem Cells, 30, 833, 10.1002/stem.1058 Lee, 2011, An increase in cancer stem cell population after primary systemic therapy is a poor prognostic factor in breast cancer, British Journal of Cancer, 104, 1730, 10.1038/bjc.2011.159 Liang, 2010, Switching of the core structures of glycosphingolipids from globo- and lacto- to ganglio-series upon human embryonic stem cell differentiation, Proceedings of the National Academy of Sciences of the United States of America, 107, 22564, 10.1073/pnas.1007290108 Liu, 2010, Glucosylceramide synthase upregulates MDR1 expression in the regulation of cancer drug resistance through cSrc and beta-catenin signaling, Molecular Cancer, 9, 145, 10.1186/1476-4598-9-145 Liu, 1999, Expression of glucosylceramide synthase, converting ceramide to glucosylceramide, confers adriamycin resistance in human breast cancer cells, Journal of Biological Chemistry, 274, 1140, 10.1074/jbc.274.2.1140 Liu, 2001, Ceramide glycosylation potentiates cellular multidrug resistance, FASEB Journal, 15, 719, 10.1096/fj.00-0223com Liu, 2011, Glucosylceramide synthase, a factor in modulating drug resistance, is overexpressed in metastatic breast carcinoma, International Journal of Oncology, 39, 425 Liu, 2008, A role for ceramide in driving cancer cell resistance to doxorubicin, FASEB Journal, 22, 2541, 10.1096/fj.07-092981 Maugeri-Sacca, 2011, Cancer stem cells and chemosensitivity, Clinical Cancer Research, 17, 4942, 10.1158/1078-0432.CCR-10-2538 Mehta, 1994, High levels of transglutaminase expression in doxorubicin-resistant human breast carcinoma cells, International Journal of Cancer, 58, 400, 10.1002/ijc.2910580316 Moore, 2006, Hematopoietic support with moderately myelosuppressive chemotherapy regimens: a nursing perspective, Clinical Journal of Oncology Nursing, 10, 383, 10.1188/06.CJON.383-388 Nurgalieva, 2010, Chemotherapy use and risk of bone marrow suppression in a large population-based cohort of older women with breast and ovarian cancer, Medical Oncology Patwardhan, 2010, Direct assessment of P-glycoprotein efflux to determine tumor response to chemotherapy, Biochemical Pharmacology, 80, 72, 10.1016/j.bcp.2010.03.010 Patwardhan, 2011, Sphingolipids and expression regulation of genes in cancer, Progress in Lipid Research, 50, 104, 10.1016/j.plipres.2010.10.003 Patwardhan, 2009, A new mixed-backbone oligonucleotide against glucosylceramide synthase sensitizes multidrug-resistant tumors to apoptosis, PLoS One, 4, e6938, 10.1371/journal.pone.0006938 Repetto, 2009, Incidence and clinical impact of chemotherapy induced myelotoxicity in cancer patients: an observational retrospective survey, Critical Reviews in Oncology/Hematology, 72, 170, 10.1016/j.critrevonc.2009.03.004 Richardson, 1997, Anthracyclines in haematology: preclinical studies, toxicity and delivery systems, Blood Reviews, 11, 201, 10.1016/S0268-960X(97)90020-5 Scharenberg, 2002, The ABCG2 transporter is an efficient Hoechst 33342 efflux pump and is preferentially expressed by immature human hematopoietic progenitors, Blood, 99, 507, 10.1182/blood.V99.2.507 Seidman, 2006, Systemic treatment of breast cancer. Two decades of progress, Oncology (Williston Park), 20, 983 Shafee, 2008, Cancer stem cells contribute to cisplatin resistance in Brca1/p53-mediated mouse mammary tumors, Cancer Research, 68, 3243, 10.1158/0008-5472.CAN-07-5480 Shiota, 2007, Isolation and characterization of bone marrow-derived mesenchymal progenitor cells with myogenic and neuronal properties, Experimental Cell Research, 313, 1008, 10.1016/j.yexcr.2006.12.017 Szakacs, 2006, Targeting multidrug resistance in cancer, Nature Reviews Drug Discovery, 5, 219, 10.1038/nrd1984 Tanei, 2009, Association of breast cancer stem cells identified by aldehyde dehydrogenase 1 expression with resistance to sequential Paclitaxel and epirubicin-based chemotherapy for breast cancers, Clinical Cancer Research, 15, 4234, 10.1158/1078-0432.CCR-08-1479 Thomson, 1998, Embryonic stem cell lines derived from human blastocysts, Science, 282, 1145, 10.1126/science.282.5391.1145 Timmer-Bonte, 2005, Prevention of chemotherapy-induced febrile neutropenia by prophylactic antibiotics plus or minus granulocyte colony-stimulating factor in small-cell lung cancer: a Dutch Randomized Phase III Study, Journal of Clinical Oncology, 23, 7974, 10.1200/JCO.2004.00.7955 Wang, 2006, Cancer therapy-induced residual bone marrow injury-Mechanisms of induction and implication for therapy, Curruent Cancer Therapy Reviews, 2, 271, 10.2174/157339406777934717 Weilbaecher, 1991, Culture of phenotypically defined hematopoietic stem cells and other progenitors at limiting dilution on Dexter monolayers, Blood, 78, 945, 10.1182/blood.V78.4.945.945 Yilmaz, 2006, SLAM family markers are conserved among hematopoietic stem cells from old and reconstituted mice and markedly increase their purity, Blood, 107, 924, 10.1182/blood-2005-05-2140 Zhou, 2002, Bcrp1 gene expression is required for normal numbers of side population stem cells in mice, and confers relative protection to mitoxantrone in hematopoietic cells in vivo, Proceedings of the National Academy of Sciences of the United States of America, 99, 12339, 10.1073/pnas.192276999 Zhou, 2001, The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype, Nature Medicine, 7, 1028, 10.1038/nm0901-1028